ENDPOINTS NEWS7h
Genen­tech joins suits against STD clin­ics it says get 'un­law­ful' 340B dis­counts
Genentech sues federal government over 340B discounts to STD clinics, joining Amgen, Eli Lilly and UCB in challenging program eligibility.
Is Big Pharma About To Win? Goldman Sachs Weighs In On 340B And Medicaid Shifts
Goldman Sachs analyst Salveen Richter highlights potential benefits for biopharma from 340B reforms, while Medicaid cuts ...
Modern Healthcare9h
Where Medicaid covers the most children, adults by state
Providers have expressed concerns that potential cuts to the program could lead to an increase in uncompensated care.
nptelegraph10h
Next week's Unicam hearings include Medicaid, youth social media use
Unicameral committees start taking testimony at 1:30 p.m. on bills scheduled that day. Livestreams of hearings and texts of ...
STAT13h
Pharmalittle: We’re reading about FDA OK for Vertex non-opioid pain drug, vaccine advisory committee, and more
Vertex Pharmaceuticals won approval from the U.S. Food and Drug Administration for a non-opioid pain drug, clearing the way for the rollout of a product that has simultaneously sparked high hopes and ...